These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 23965767)
21. Potential deleterious effects of promoting the use of ceftriaxone in the treatment of Neisseria gonorrhoeae. Golden MR; Barbee LA; Kerani R; Dombrowski JC Sex Transm Dis; 2014 Oct; 41(10):619-25. PubMed ID: 25211259 [TBL] [Abstract][Full Text] [Related]
22. Multicenter trial of single-dose azithromycin vs. ceftriaxone in the treatment of uncomplicated gonorrhea. Azithromycin Gonorrhea Study Group. Handsfield HH; Dalu ZA; Martin DH; Douglas JM; McCarty JM; Schlossberg D Sex Transm Dis; 1994; 21(2):107-11. PubMed ID: 9071422 [TBL] [Abstract][Full Text] [Related]
23. ACOG Committee Opinion No. 645: Dual Therapy for Gonococcal Infections. Committee on Gynecologic Practice Obstet Gynecol; 2015 Nov; 126(5):e95-9. PubMed ID: 26488526 [TBL] [Abstract][Full Text] [Related]
24. ACOG Committee Opinion No. 645 Summary: Dual Therapy for Gonococcal Infections. Committee on Gynecologic Practice Obstet Gynecol; 2015 Nov; 126(5):1126. PubMed ID: 26488518 [TBL] [Abstract][Full Text] [Related]
25. Adherence to CDC Recommendations for the Treatment of Uncomplicated Gonorrhea - STD Surveillance Network, United States, 2016. Weston EJ; Workowski K; Torrone E; Weinstock H; Stenger MR MMWR Morb Mortal Wkly Rep; 2018 Apr; 67(16):473-476. PubMed ID: 29698384 [TBL] [Abstract][Full Text] [Related]
26. Comparing ceftriaxone plus azithromycin or doxycycline for pelvic inflammatory disease: a randomized controlled trial. Savaris RF; Teixeira LM; Torres TG; Edelweiss MI; Moncada J; Schachter J Obstet Gynecol; 2007 Jul; 110(1):53-60. PubMed ID: 17601896 [TBL] [Abstract][Full Text] [Related]
27. Single-dose cefixime 800 mg plus doxycycline 100 mg twice a day for 7 days compared with single-dose ceftriaxone 1 g plus single-dose azithromycin 2 g for treatment of urogenital, rectal, and pharyngeal gonorrhoea: a randomised clinical trial. Bížová B; Procházka P; Nyčová E; Bořil P; Kubele J; Poláková A; Zemanová Z; Unemo M; Rob F Clin Microbiol Infect; 2024 Feb; 30(2):211-215. PubMed ID: 37981059 [TBL] [Abstract][Full Text] [Related]
28. Gentamicin 240 mg plus azithromycin 2 g vs. ceftriaxone 500 mg plus azithromycin 2 g for treatment of rectal and pharyngeal gonorrhoea: a randomized controlled trial. Rob F; Klubalová B; Nyčová E; Hercogová J; Unemo M Clin Microbiol Infect; 2020 Feb; 26(2):207-212. PubMed ID: 31419483 [TBL] [Abstract][Full Text] [Related]
29. Retrospective analysis of antimicrobial susceptibility trends (2000-2009) in Neisseria gonorrhoeae isolates from countries in Latin America and the Caribbean shows evolving resistance to ciprofloxacin, azithromycin and decreased susceptibility to ceftriaxone. Starnino S; ; Galarza P; Carvallo ME; Benzaken AS; Ballesteros AM; Cruz OM; Hernandez AL; Carbajal JL; Borthagaray G; Payares D; Dillon JA Sex Transm Dis; 2012 Oct; 39(10):813-21. PubMed ID: 23001269 [TBL] [Abstract][Full Text] [Related]
31. A Case of Persistent and Possibly Treatment Resistant Pharyngeal Gonorrhea. Levy V; Pandori M; Berrada ZL; Relucio KI; Lopez TP; Samuel MC; Park IU Sex Transm Dis; 2016 Apr; 43(4):258-9. PubMed ID: 26967304 [TBL] [Abstract][Full Text] [Related]
32. Gentamicin compared with ceftriaxone for the treatment of gonorrhoea (G-ToG): a randomised non-inferiority trial. Ross JDC; Brittain C; Cole M; Dewsnap C; Harding J; Hepburn T; Jackson L; Keogh M; Lawrence T; Montgomery AA; Roberts TE; Sprange K; Tan W; Thandi S; White J; Wilson J; Duley L; Lancet; 2019 Jun; 393(10190):2511-2520. PubMed ID: 31056291 [TBL] [Abstract][Full Text] [Related]
33. Solithromycin versus ceftriaxone plus azithromycin for the treatment of uncomplicated genital gonorrhoea (SOLITAIRE-U): a randomised phase 3 non-inferiority trial. Chen MY; McNulty A; Avery A; Whiley D; Tabrizi SN; Hardy D; Das AF; Nenninger A; Fairley CK; Hocking JS; Bradshaw CS; Donovan B; Howden BP; Oldach D; Lancet Infect Dis; 2019 Aug; 19(8):833-842. PubMed ID: 31196813 [TBL] [Abstract][Full Text] [Related]
34. Cephalosporin and azithromycin susceptibility in Neisseria gonorrhoeae isolates by site of infection, British Columbia, 2006 to 2011. Hottes TS; Lester RT; Hoang LM; McKay R; Imperial M; Gilbert M; Patrick D; Wong T; Martin I; Ogilvie G Sex Transm Dis; 2013 Jan; 40(1):46-51. PubMed ID: 23250301 [TBL] [Abstract][Full Text] [Related]
35. The efficacy and safety of gentamicin plus azithromycin and gemifloxacin plus azithromycin as treatment of uncomplicated gonorrhea. Kirkcaldy RD; Weinstock HS; Moore PC; Philip SS; Wiesenfeld HC; Papp JR; Kerndt PR; Johnson S; Ghanem KG; Hook EW Clin Infect Dis; 2014 Oct; 59(8):1083-91. PubMed ID: 25031289 [TBL] [Abstract][Full Text] [Related]
36. Concurrent patient-partner treatment in pregnancy: an alternative to expedited partner therapy? Mmeje O; Coleman JS Sex Transm Dis; 2012 Sep; 39(9):665-70. PubMed ID: 22902661 [TBL] [Abstract][Full Text] [Related]
37. Efficacy and Safety of Single-Dose Oral Delafloxacin Compared With Intramuscular Ceftriaxone for Uncomplicated Gonorrhea Treatment: An Open-Label, Noninferiority, Phase 3, Multicenter, Randomized Study. Hook EW; Golden MR; Taylor SN; Henry E; Tseng C; Workowski KA; Swerdlow J; Nenninger A; Cammarata S Sex Transm Dis; 2019 May; 46(5):279-286. PubMed ID: 30985632 [TBL] [Abstract][Full Text] [Related]
38. Evaluation of single-dose azithromycin versus standard azithromycin/doxycycline treatment and clinical assessment of regression course in patients with adult inclusion conjunctivitis. Malamos P; Georgalas I; Rallis K; Andrianopoulos K; Georgopoulos G; Theodossiadis P; Vergados I; Markomichelakis NN Curr Eye Res; 2013 Dec; 38(12):1198-206. PubMed ID: 24047438 [TBL] [Abstract][Full Text] [Related]
39. A retrospective comparative study of 2-drug oral and intramuscular cephalosporin treatment regimens for pharyngeal gonorrhea. Barbee LA; Kerani RP; Dombrowski JC; Soge OO; Golden MR Clin Infect Dis; 2013 Jun; 56(11):1539-45. PubMed ID: 23408680 [TBL] [Abstract][Full Text] [Related]